⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31321036 | 0.86 | — | — | |
| Quinoline SCHEMBL27346816 | 0.79 | ALDH1A1 (0.50) | — | |
| SCHEMBL25816394 | 0.79 | HDAC1 (0.42) | — | |
| SCHEMBL28091306 | 0.78 | KAT2B (0.32) | — | |
| SCHEMBL11577577 | 0.76 | — | — | |
| SCHEMBL22708167 | 0.74 | — | — | |
| SCHEMBL4419350 | 0.74 | HDAC1 (0.46) | — | |
| SCHEMBL6981903 | 0.73 | KMT2A (0.43) | — | |
| Formamide SCHEMBL10967419 | 0.73 | KEAP1 (0.39) | — | |
| SCHEMBL25610512 | 0.73 | HDAC1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 560 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120058610-A | Salicyloyl hydrazine derivative containing pyrazole group with optical switching performance, preparation method and application | 南京理工大学 | 2025-05-30 | — | — | CN | claimed |
| EP-4013755-B1 | PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS | NOVARTIS AG (CH) | 2025-01-08 | — | — | EP | claimed |
| CN-111936144-A | JAK inhibitors | 廖细斌 | 2020-11-13 | — | — | CN | claimed |
| EP-2776407-A1 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2014-09-17 | — | — | EP | claimed |
| WO-2013070657-A1 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2013-05-16 | — | — | WO | claimed |
| EP-1828175-A2 | PROCESS FOR OBTAINING ENANTIOMERS OF THIENYLAZOLYLALCOXYETHANAMINES | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-09-05 | — | — | EP | claimed |
| US-7078531-B2 | Process for obtaining enantiomers of thienylazolylalcoxyethanamines | LABORATORIES DEL DR. ESTEVE, S.A. (ES) | 2006-07-18 | — | — | US | claimed |
| WO-2006063860-A2 | PROCESS FOR OBTAINING ENANTIOMERS OF THIENYLAZOLYLALCOXYETHANAMINES | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2006-06-22 | — | — | WO | claimed |
| US-20060135787-A1 | PROCESS FOR OBTAINING ENANTIOMERS OF THIENYLAZOLYLALCOXYETHANAMINES | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2006-06-22 | — | — | US | claimed |
| EP-1671968-A1 | Process for obtaining enantiomers of thienylazolylalcoxyethanamines | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2006-06-21 | — | — | EP | claimed |
| EP-4745117-A1 | NOVEL INDENONE DERIVATIVE AND USE THEREOF | Amyloid Solution Inc. (KR) | 2026-05-20 | — | — | EP | disclosed |
| US-20260125384-A1 | INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF | VENTUS THERAPEUTICS U.S., INC. (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260098041-A1 | FUSED BICYCLIC PYRIMIDONES AS WRN INHIBITORS | INCYTE CORPORATION (US) | 2026-04-09 | — | — | US | disclosed |
| US-12577247-B2 | Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2A receptor and adenosine 2B receptor antagonist | Bugworks Research, Inc. (US) | 2026-03-17 | — | — | US | disclosed |
| CN-121574101-A | Preparation method and application of quinazoline compound | 厦门大学 | 2026-02-27 | — | — | CN | disclosed |
| EP-1324985-A4 | INHIBITORS OF PRENYL-PROTEIN TRANSFERASE | MERCK & CO INC (US) | 2004-10-06 | — | — | EP | disclosed |
| WO-2004058702-A2 | 4-[(4-(CARBOXYETHYL) PIPERIDINYL) METHYL] PYRROLIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO., INC. (US) | 2004-07-15 | — | — | WO | disclosed |
| WO-2004058763-A1 | 4(SPIROPIPERIDINYL)METHYL SUBSTITUTED PYRROLIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO., INC. (US) | 2004-07-15 | — | — | WO | disclosed |
| EP-1324985-A1 | INHIBITORS OF PRENYL-PROTEIN TRANSFERASE | Merck & Co., Inc. (US) | 2003-07-09 | — | — | EP | disclosed |
| WO-2002028831-A1 | INHIBITORS OF PRENYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 2002-04-11 | — | — | WO | disclosed |